HCS
OGEN icon

Harvest Capital Strategies’s Oragenics OGEN Stock Holding History

Harvest Capital Strategies’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$720K Hold
741
– – 0.98% 23
2019
Q2 		$653K Hold
741
– – 0.91% 22
2019
Q1 		$780K Buy
+741
New +$1.17M 1.1% 22

Other funds holding OGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Harvest Capital Strategies's OGEN Position: Q3 2019 in Review

Harvest Capital Strategies held its Oragenics (OGEN) position steady in Q3 2019 at 741 shares worth $720K. The position accounts for 0.98% of the portfolio, ranked #23.

Harvest Capital Strategies first reported a position in OGEN in Q1 2019 and has held it in 3 quarters since. The position peaked at $780K in Q1 2019. 13 funds tracked by Wall St. Rank hold OGEN as of Q3 2019.

  • Harvest Capital Strategies held 741 shares of Oragenics worth $720K as of Q3 2019.
  • Harvest Capital Strategies left its Oragenics share count unchanged in Q3 2019.
  • Oragenics made up 0.98% of Harvest Capital Strategies's portfolio in Q3 2019, its #23 holding.
  • Harvest Capital Strategies first reported a position in Oragenics in Q1 2019 and has held it in 3 quarters since.
  • Harvest Capital Strategies's Oragenics position peaked at $780K in Q1 2019.
  • 13 funds tracked by Wall St. Rank held Oragenics as of Q3 2019.

Based on Harvest Capital Strategies's 13F filing for Q3 2019, filed 14 Nov 2019.